Rival Opioid Makers Sought To Cash In On Alarm Over OxyContin’s Dangers
When critics attacked Purdue Pharma for deaths linked to OxyContin, rivals stepped up their marketing of other potentially dangerous painkillers, such as fentanyl and morphine.
As Purdue Pharma faced mounting criticism over deaths linked to OxyContin, rival drugmakers saw a chance to boost sales by stepping up marketing of similarly dangerous painkillers, such as fentanyl, morphine and methadone, Purdue internal documents reveal.
